The chemical potential of the immune system was underscored when it was shown in 1986 that antibodies raised to tetrahedral, negatively-charged phosphate and phosphonate transition state analogues were capable of selectively catalyzing the hydrolysis of carbonates and esters, respectively. Since that time antibodies have been generated that selectively catalyze a wide array of chemical reactions. Because antibodies can be generated that bind almost any molecule of interest, this new technology offers the potential to tailormake highly selective catalysts for applications in biology, chemistry and medicine. In addition, catalytic antibodies provide fundamental insight into important aspects of biological catalysis, including the importance of transition-state stabilization, proximity effects, general acid and base catalysts, electrophilic and nucleophilic catalysis, and strain.
Our specific aims i n this proposal are (1) to characterize the catalytic mechanisms and structures of three previously generated catalytic antibodies - a chorismate mutase, nucleoside acylase and cis-- trans enone isomerase. This work will provide important mechanistic information into the nature of antibody catalysis that will be relevant to the generation of more efficient catalytic antibodies, (2) to use selection schemes coupled with random mutagenesis to increase the catalytic efficiencies of existing antibodies. This may prove a powerful general strategy for optimizing antibody catalysts, (3) to develop general strategies for generating antibodies that selectively cleave amide bonds. This work might lead to sequence specific peptidases for applications in biology and medicine and (4) to generate and characterize antibodies that catalyze rotation around a sigma bond, a mechanistically simple unimolecular reaction in which transition state stabilization can be easily quantitated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI024695-06
Application #
3137853
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1987-04-01
Project End
1997-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California Berkeley
Department
Type
Schools of Arts and Sciences
DUNS #
094878337
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Romesberg, F E; Schultz, P G (1999) A mutational study of a Diels-Alderase catalytic antibody. Bioorg Med Chem Lett 9:1741-4
Romesberg, F E; Santarsiero, B D; Spiller, B et al. (1998) Structural and kinetic evidence for strain in biological catalysis. Biochemistry 37:14404-9
Pedersen, H; Holder, S; Sutherlin, D P et al. (1998) A method for directed evolution and functional cloning of enzymes. Proc Natl Acad Sci U S A 95:10523-8
Hsieh-Wilson, L C; Schultz, P G; Stevens, R C (1996) Insights into antibody catalysis: structure of an oxygenation catalyst at 1.9-angstrom resolution. Proc Natl Acad Sci U S A 93:5363-7
Jacobsen, J R; Schultz, P G (1995) The scope of antibody catalysis. Curr Opin Struct Biol 5:818-24
Jacobsen, J R; Schultz, P G (1994) Antibody catalysis of peptide bond formation. Proc Natl Acad Sci U S A 91:5888-92
Lesley, S A; Patten, P A; Schultz, P G (1993) A genetic approach to the generation of antibodies with enhanced catalytic activities. Proc Natl Acad Sci U S A 90:1160-5
Jacobsen, J R; Prudent, J R; Kochersperger, L et al. (1992) An efficient antibody-catalyzed aminoacylation reaction. Science 256:365-7
Pollack, S J; Nakayama, G R; Schultz, P G (1988) Introduction of nucleophiles and spectroscopic probes into antibody combining sites. Science 242:1038-40
Schultz, P G (1988) The interplay between chemistry and biology in the design of enzymatic catalysts. Science 240:426-33